SynCore Biotechnology Co.,Ltd (TPEX:4192)

TPEX:4192 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	858	1,225	1,350	2,923	3,654	4,977
Market Cap Growth	-35.45%	-9.25%	-53.80%	-20.00%	-26.59%	70.39%
Enterprise Value	684	1,018	1,200	2,702	3,163	4,585
Last Close Price	24.40	34.85	38.40	93.59	116.99	172.07
PS Ratio	32.68	52.51	66.86	184.33	526.54	373.21
PB Ratio	3.33	4.16	3.78	11.74	8.25	8.88
P/TBV Ratio	3.91	4.89	4.41	15.34	10.13	11.20
EV/Sales Ratio	26.05	43.63	59.41	170.43	455.86	343.79
Debt / Equity Ratio	0.02	0.03	0.01	0.29	0.28	0.41
Asset Turnover	0.09	0.07	0.05	0.03	0.01	0.02
Inventory Turnover	0.86	1.58	1.00	0.09	0.03	0.05
Quick Ratio	14.60	11.19	14.41	1.65	1.55	1.59
Current Ratio	15.34	11.77	14.63	1.87	1.86	2.13
Return on Equity (ROE)	-16.29%	-16.66%	-12.60%	-54.53%	-91.40%	-68.04%
Return on Assets (ROA)	-10.12%	-10.37%	-6.98%	-18.98%	-32.98%	-29.48%
Return on Capital Employed (ROCE)	-19.00%	-19.50%	-12.70%	-76.60%	-103.50%	-69.90%
Earnings Yield	-5.41%	-4.43%	-2.83%	-6.46%	-12.55%	-8.02%
FCF Yield	-3.50%	-4.04%	-6.13%	-7.18%	-6.30%	-6.46%
Buyback Yield / Dilution	0.59%	-9.69%	-4.27%	-1.26%	-9.16%	-15.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.